Your browser doesn't support javascript.
loading
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Porta, Camillo; Bamias, Aristotelis; Zakopoulou, Roubini; Myint, Zin W; Cavasin, Nicolò; Iacovelli, Roberto; Pichler, Martin; Kopecky, Jindrich; Kucharz, Jakub; Rizzo, Mimma; Galli, Luca; Büttner, Thomas; DE Giorgi, Ugo; Kanesvaran, Ravindran; Fiala, Ondrej; Grande, Enrique; Zucali, Paolo A; Kopp, Ray M; Fornarini, Giuseppe; Bourlon, Maria T; Scagliarini, Sarah; Molina-Cerrillo, Javier; Aurilio, Gaetano; Matrana, Marc R; Pichler, Renate; Cattrini, Carlo; Büchler, Tomás; Massari, Francesco; Mollica, Veronica; Seront, Emmanuel; Calabrò, Fabio; Pinto, Alvaro; Berardi, Rossana; Zgura, Anca; Mammone, Giulia; Ansari, Jawaher; Atzori, Francesco; Chiari, Rita; Caffo, Orazio; Procopio, Giuseppe; Sunela, Kaisa; Bassanelli, Maria; Ortega, Cinzia; Grillone, Francesco; Landmesser, Johannes; Merler, Sara; Messina, Carlo; Küronya, Zsófia; Mosca, Alessandra; Bhuva, Dipen.
Afiliação
  • Porta C; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy.
  • Bamias A; Chair of Oncology, Interdisciplinary Department of Medicine, Aldo Moro University of Bari, Bari, Italy.
  • Zakopoulou R; Second Propedeutic Department of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Myint ZW; Second Propedeutic Department of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Cavasin N; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Iacovelli R; Oncology3 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.
  • Pichler M; Oncologia Medica, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.
  • Kopecky J; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Kucharz J; Department of Clinical Oncology and Radiotherapy, University Hospital of Hradec Kralove, Hradec Kralove, Czech Republic.
  • Rizzo M; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Galli L; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy.
  • Büttner T; Oncology Unit2, University Hospital of Pisa, Pisa, Italy.
  • DE Giorgi U; Department of Urology, University Hospital Bonn UKB, Bonn, Germany.
  • Kanesvaran R; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì-Cesena, Italy.
  • Fiala O; Division of Medical Oncology, National Cancer Center Singapore, Singapore.
  • Grande E; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Zucali PA; Department of Medical Oncology, MD Anderson Cancer Center of Madrid, Madrid, Spain.
  • Kopp RM; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Fornarini G; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Bourlon MT; Clinical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia.
  • Scagliarini S; IRCCS San Martino University Hospital Genoa, Italy.
  • Molina-Cerrillo J; Department of Hematology and Oncology, Salvador Zubirán National Institute of Medical and Nutritional Sciences, Mexico City, Mexico.
  • Aurilio G; Unit of Oncology, Azienda Ospedaliera di Rilievo Nazionale Cardarelli of Naples, Naples, Italy.
  • Matrana MR; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.
  • Pichler R; Medical Oncology Division of Urogenital and Head and Neck Tumors, European Institute of Oncology IEO IRCCS, Milan, Italy.
  • Cattrini C; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA, USA.
  • Büchler T; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
  • Massari F; Department of Medical Oncology, Maggiore della Carità University Hospital, Novara, Italy.
  • Mollica V; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic.
  • Seront E; Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Calabrò F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy - francesco.massari@aosp.bo.it.
  • Pinto A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Berardi R; Department of Medical Oncology, Jolimont Hospital Center, Haine Saint Paul, Belgium.
  • Zgura A; Department of Oncology, San Camillo Forlanini Hospital, Rome, Italy.
  • Mammone G; Department of Medical Oncology, La Paz University Hospital, Madrid, Spain.
  • Ansari J; Department of Medical Oncology, AOU Ospedali Riuniti delle Marche, Marche Polytechnic University, Ancona, Italy.
  • Atzori F; Department of Oncology-Radiotherapy, Prof. Dr. Alexandru Trestioreanu Institute of Oncology, University of Medicine and Pharmacy, Bucharest, Romania.
  • Chiari R; Department of Radiological, Oncological and Anatomo-Pathological Science, Sapienza University of Rome, Rome, Italy.
  • Caffo O; Department of Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates.
  • Procopio G; Unit of Medical Oncology, University Hospital of Cagliari, Cagliari, Italy.
  • Sunela K; Unit of Oncology, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Italy.
  • Bassanelli M; Unit of Medical Oncology, Santa Chiara Hospital, Trento, Italy.
  • Ortega C; Department of Medical Oncology, IRCCS Istituto Nazionale Tumori Foundation, Milan, Italy.
  • Grillone F; Department of Medical Oncology, Ospedale Maggiore of Cremona, Cremona, Italy.
  • Landmesser J; Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
  • Merler S; Department of Medical Oncology1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Messina C; Division of Oncology, Institute for Cancer Research and Treatment, Asl Cn2 Alba-Bra, Alba, Cuneo, Italy.
  • Küronya Z; Unit of Medical Oncology, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
  • Mosca A; Clinic of Urology, Lübeck, Germany.
  • Bhuva D; Section of Oncology, Department of Medicine, University of Verona School of Medicine, Verona University Hospital, Verona, Italy.
Minerva Urol Nephrol ; 75(4): 460-470, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37530662
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2023 Tipo de documento: Article